SynthesisCardiovascular intervention and therapeutics2025

Efficacy and safety of low-dose prasugrel as dual antiplatelet therapy in patients with ischemic heart disease: a systematic review and network meta-analysis of randomized controlled trials.

Toshiharu Fujii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.